Last edition
News about "Glenmark Pharma receives US FDA approval for gener"
Glenmark Pharma receives US FDA approval for generic Firazyr injection
Glenmark Pharmaceuticals Limited has received final approval by the United States Food & Drug Administration (FDA) for icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, the generic version of Firazyr injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, of Shire Human Genetic Therapies, Inc
Glenmark Pharma Receives US FDA Approval For Gener | 24/05/2021 | By Darshana | 154
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy